Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma

BACKGROUND: Recurrent head and neck squamous cell carcinoma (rHNSCC) represents a significant global health burden with an unmet medical need. In this study we determined the safety and efficacy of RM‐1929 photoimmunotherapy in patients with heavily pretreated rHNSCC. METHODS: RM‐1929 (anti‐EGFR–IR7...

Descripción completa

Detalles Bibliográficos
Autores principales: Cognetti, David M., Johnson, Jennifer M., Curry, Joseph M., Kochuparambil, Samith T., McDonald, Darren, Mott, Frank, Fidler, Mary J., Stenson, Kerstin, Vasan, Nilesh R., Razaq, Mohammad A., Campana, John, Ha, Patrick, Mann, Grace, Ishida, Kosuke, Garcia‐Guzman, Miguel, Biel, Merrill, Gillenwater, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293150/
https://www.ncbi.nlm.nih.gov/pubmed/34626024
http://dx.doi.org/10.1002/hed.26885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293150/
https://www.ncbi.nlm.nih.gov/pubmed/34626024
http://dx.doi.org/10.1002/hed.26885

Ejemplares similares